Impact of Inter- and Intrafraction Deviations and Residual Set-up Errors on PTV Margins. Different Alignment Techniques in 3D Conformal Prostate Cancer Radiotherapy

Overview

Journal Strahlenther Onkol

Specialties Oncology
Radiology

Date 2013 Feb 28

PMID 23443612

Citations 8

Authors

T Langsenlehner

C Doller

P Winkler

G Galle

K S Kapp

Affiliations

Soon will be listed here.

Abstract

Purpose: The aim of this work was to analyze interfraction and intrafraction deviations and residual set-up errors (RSE) after online repositioning to determine PTV margins for 3 different alignment techniques in prostate cancer radiotherapy.

Methods: The present prospective study included 44 prostate cancer patients with implanted fiducials treated with three-dimensional (3D) conformal radiotherapy. Daily localization was based on skin marks followed by marker detection using kilovoltage (kV) imaging and subsequent patient repositioning. Additionally, in-treatment megavoltage (MV) images were obtained for each treatment field. In an off-line analysis of 7,273 images, interfraction prostate motion, RSE after marker-based prostate localization, prostate position during each treatment session, and the effect of treatment time on intrafraction deviations were analyzed to evaluate PTV margins.

Results: Margins accounting for interfraction deviation, RSE and intrafraction motion were 14.1, 12.9, and 15.1 mm in anterior-posterior (AP), superior-inferior (SI), and left-right (LR) direction for skin mark alignment and 9.6, 8.7, and 2.6 mm for bony structure alignment, respectively. Alignment to implanted markers required margins of 4.6, 2.8, and 2.5 mm. As margins to account for intrafraction motion increased with treatment prolongation PTV margins could be reduced to 3.9, 2.6, and 2.4 mm if treatment time was ≤ 4 min.

Conclusion: With daily online correction and repositioning based on implanted fiducials, a significant reduction of PTV margins can be achieved. The use of an optimized workflow with faster treatment techniques such as volumetric modulated arc techniques (VMAT) could allow for a further decrease.

Citing Articles

Three-dimensional surface imaging for detection of intra-fraction setup variations during radiotherapy of pelvic tumors.

Apicella G, Loi G, Torrente S, Crespi S, Beldi D, Brambilla M Radiol Med. 2016; 121(10):805-10.

PMID: 27300649 DOI: 10.1007/s11547-016-0659-9.

A Dosimetric Comparison between Conventional Fractionated and Hypofractionated Image-guided Radiation Therapies for Localized Prostate Cancer.

Li M, Li G, Hou X, Gao H, Xu Y, Zhao T Chin Med J (Engl). 2016; 129(12):1447-54.

PMID: 27270540 PMC: 4910368. DOI: 10.4103/0366-6999.183429.

Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice.

Panje C, Dal Pra A, Zilli T, Zwahlen D, Papachristofilou A, Herrera F Strahlenther Onkol. 2015; 191(10):778-86.

PMID: 25986251 DOI: 10.1007/s00066-015-0849-8.

Observation of intrafraction prostate displacement through the course of conventionally fractionated radiotherapy for prostate cancer.

Hamamoto Y, Inata H, Sodeoka N, Nakayama S, Tsuruoka S, Takeda H Jpn J Radiol. 2015; 33(4):187-93.

PMID: 25663603 DOI: 10.1007/s11604-015-0396-3.

Quantification of an external motion surrogate for quality assurance in lung cancer radiation therapy.

Wolfelschneider J, Brandt T, Lettmaier S, Fietkau R, Bert C Biomed Res Int. 2014; 2014:595430.

PMID: 25525599 PMC: 4266763. DOI: 10.1155/2014/595430.

References

Pasler M, Georg D, Wirtz H, Lutterbach J . Effect of photon-beam energy on VMAT and IMRT treatment plan quality and dosimetric accuracy for advanced prostate cancer. Strahlenther Onkol. 2011; 187(12):792-8. DOI: 10.1007/s00066-011-1150-0. View

Budiharto T, Slagmolen P, Haustermans K, Maes F, Junius S, Verstraete J . Intrafractional prostate motion during online image guided intensity-modulated radiotherapy for prostate cancer. Radiother Oncol. 2011; 98(2):181-6. DOI: 10.1016/j.radonc.2010.12.019. View

Peeters S, Heemsbergen W, Koper P, van Putten W, Slot A, Dielwart M . Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol. 2006; 24(13):1990-6. DOI: 10.1200/JCO.2005.05.2530. View

Tanyi J, He T, Summers P, Mburu R, Kato C, Rhodes S . Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion. Int J Radiat Oncol Biol Phys. 2010; 78(5):1579-85. DOI: 10.1016/j.ijrobp.2010.02.001. View

Pinkawa M, Piroth M, Holy R, Djukic V, Klotz J, Krenkel B . Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer. Strahlenther Onkol. 2011; 187(8):479-84. DOI: 10.1007/s00066-011-2249-z. View

Mutanga T, de Boer H, van der Wielen G, Hoogeman M, Incrocci L, Heijmen B . Margin evaluation in the presence of deformation, rotation, and translation in prostate and entire seminal vesicle irradiation with daily marker-based setup corrections. Int J Radiat Oncol Biol Phys. 2010; 81(4):1160-7. DOI: 10.1016/j.ijrobp.2010.09.013. View

van Herk M, Remeijer P, Rasch C, Lebesque J . The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys. 2000; 47(4):1121-35. DOI: 10.1016/s0360-3016(00)00518-6. View

Liang J, Wu Q, Yan D . The role of seminal vesicle motion in target margin assessment for online image-guided radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2008; 73(3):935-43. PMC: 2662431. DOI: 10.1016/j.ijrobp.2008.10.019. View

Schallenkamp J, Herman M, Kruse J, Pisansky T . Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int J Radiat Oncol Biol Phys. 2005; 63(3):800-11. DOI: 10.1016/j.ijrobp.2005.02.022. View

10.

Graf R, Boehmer D, Budach V, Wust P . Residual translational and rotational errors after kV X-ray image-guided correction of prostate location using implanted fiducials. Strahlenther Onkol. 2010; 186(10):544-50. DOI: 10.1007/s00066-010-2030-8. View

11.

Kotte A, Hofman P, Lagendijk J, van Vulpen M, van der Heide U . Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers. Int J Radiat Oncol Biol Phys. 2007; 69(2):419-25. DOI: 10.1016/j.ijrobp.2007.03.029. View

12.

Rasch C, Steenbakkers R, Van Herk M . Target definition in prostate, head, and neck. Semin Radiat Oncol. 2005; 15(3):136-45. DOI: 10.1016/j.semradonc.2005.01.005. View

13.

Geier M, Astner S, Duma M, Jacob V, Nieder C, Putzhammer J . Dose-escalated simultaneous integrated-boost treatment of prostate cancer patients via helical tomotherapy. Strahlenther Onkol. 2012; 188(5):410-6. DOI: 10.1007/s00066-012-0081-8. View

14.

Adamson J, Wu Q, Yan D . Dosimetric effect of intrafraction motion and residual setup error for hypofractionated prostate intensity-modulated radiotherapy with online cone beam computed tomography image guidance. Int J Radiat Oncol Biol Phys. 2010; 80(2):453-61. PMC: 3010484. DOI: 10.1016/j.ijrobp.2010.02.033. View

15.

Hoogeman M, Van Herk M, de Bois J, Lebesque J . Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer. Radiother Oncol. 2005; 74(2):177-85. DOI: 10.1016/j.radonc.2004.12.010. View

16.

Prokic V, Geinitz H, Kneschaurek P . Reduction of dosimetric impact of intrafractional prostate motion during helical tomotherapy. Strahlenther Onkol. 2012; 188(5):404-9. DOI: 10.1007/s00066-011-0048-1. View

17.

Al-Mamgani A, van Putten W, Heemsbergen W, van Leenders G, Slot A, Dielwart M . Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008; 72(4):980-8. DOI: 10.1016/j.ijrobp.2008.02.073. View

18.

Rijkhorst E, Van Herk M, Lebesque J, Sonke J . Strategy for online correction of rotational organ motion for intensity-modulated radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 2007; 69(5):1608-17. DOI: 10.1016/j.ijrobp.2007.08.042. View

19.

Litzenberg D, Balter J, Hadley S, Hamstra D, Willoughby T, Kupelian P . Prostate intrafraction translation margins for real-time monitoring and correction strategies. Prostate Cancer. 2011; 2012:130579. PMC: 3195290. DOI: 10.1155/2012/130579. View

20.

Zietman A, Bae K, Slater J, Shipley W, Efstathiou J, Coen J . Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09. J Clin Oncol. 2010; 28(7):1106-11. PMC: 2834463. DOI: 10.1200/JCO.2009.25.8475. View